SCHEMBL19937883

SCHEMBL19937883

CNc1cccc(-c2cccc(OCCCN3CCCC3)c2C)c1C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.56
CYP2C19 P33261 1/20 0.56
ALDH1A1 P00352 7/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
L3MBTL1 Q9Y468 2/20 0.48
HTT P42858 1/20 0.48
HRH1 P35367 3/20 0.48
DRD2 P14416 1/20 0.48
DRD1 P21728 1/20 0.48
DRD4 P21917 1/20 0.48
DRD5 P21918 1/20 0.48
DRD3 P35462 1/20 0.48
HRH3 Q9Y5N1 3/20 0.47
KDM4E B2RXH2 2/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
PKM P14618 1/20 0.47
CYP1A2 P05177 1/20 0.47
TDP1 Q9NUW8 2/20 0.47
KCNH2 Q12809 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24445406 0.89 CYP2D6 (0.68) CYP2D6CYP2C19ALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL19916129 0.88 CYP2D6 (0.66) CYP2D6CYP2C19ALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL24445444 0.88 CYP2D6 (0.66) CYP2D6CYP2C19ALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL19916125 0.88 CYP2D6 (0.53) CYP2D6CYP2C19ALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL26194821 0.84 CYP2D6 (0.69) CYP2D6CYP2C19ALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL19916130 0.83 CYP2D6 (0.59) CYP2D6CYP2C19ALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL19916122 0.83 CYP2D6 (0.59) CYP2D6CYP2C19ALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL24445402 0.82 CYP2D6 (0.58) CYP2D6CYP2C19ALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL19937782 0.82 SMN1; SMN2 (0.62) CYP2D6CYP2C19ALDH1A1SMN1; SMN2HRH3
SCHEMBL26194024 0.80 CYP2D6 (0.63) CYP2D6CYP2C19ALDH1A1SMN1; SMN2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018044963-A1 BIARYL COMPOUNDS USEFUL AS IMMUNOMODULATORS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-03-08 WO disclosed